Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Vielight Inc.
Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology
Today 8:00 EDT
From
Vielight Inc.
Via
GlobeNewswire
Protecting Football Players’ Brains: Breakthrough Study Reinforces Vielight’s Red-Light Therapy Technology
January 23, 2026
From
Vielight Inc.
Via
GlobeNewswire
New Randomized Trial Shows Promising Cognitive Gains in Long COVID Brain Fog Using Home-Based Light Therapy
January 14, 2026
From
Vielight Inc.
Via
GlobeNewswire
University of Toronto Researchers Report Real-Time Brain Fluid Modulation Using Vielight Photobiomodulation
January 08, 2026
From
Vielight Inc.
Via
GlobeNewswire
Vielight Inc. Enhances Meditation Practices with Groundbreaking Technology and Announces New Neuroscience of Meditation Summit
October 01, 2025
From
Vielight Inc.
Via
GlobeNewswire
Vielight Unveils the First Photobiomodulation-Based Vagus Nerve Stimulation Device Following Patent Approval
September 16, 2025
From
Vielight Inc.
Via
GlobeNewswire
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
September 02, 2025
From
Vielight Inc.
Via
GlobeNewswire
Vielight Unveils Neuro Pro 2: The Most Advanced Transcranial Photobiomodulation Device to Date
February 05, 2025
From
Vielight Inc.
Via
GlobeNewswire
Vielight Starts Clinical Trial to Study Photobiomodulation Device Treatment for Post-Covid Cognitive Impairment
July 26, 2023
From
Vielight Inc.
Via
GlobeNewswire
Vielight Founder, Dr. Lew Lim Granted a Patent for Artificial Intelligence (AI) Brain Stimulation & Assigns to Vielight Inc.
July 13, 2023
From
Vielight Inc.
Via
GlobeNewswire
Vielight Inc. Receives Health Canada Approval for Treatment of Covid-19 with Near Infrared Device Technology
May 25, 2023
From
Vielight Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.